glutathione vs mercaptoethanol - an overview Protein Modification, Bioconjugation, and Disulfide
Description
A single-arm Phase 3b clinical trial (NCT01702571) evaluating T-DM1 in patients with HER2 + MBC and brain metastases revealed that T-DM1 is efficacious and well-tolerated
doi: 10.1155/2018/4701275
doi: 10.3233/JAD-130101
J.Mamum-Or-RashidA.PangM
Structural abnormalities, bone-related problems, and advanced degenerative changes show limited response regardless of treatment duration
doi: 10.7554/eLife.89750.3.sa2 29 BrunnerJSBridgemanAEJacksonBTChakrabortySFagoaga-EuguiMParasKIet al
